| Literature DB >> 25478794 |
Makiko Orita1, Naomi Hayashida1, Hiroshi Nukui1, Naoko Fukuda2, Takashi Kudo2, Naoki Matsuda3, Yoshiko Fukushima4, Noboru Takamura1.
Abstract
As a result of the accident at the Fukushima Daiichi Nuclear Power Plant (FNPP) on 11 March 2011, a huge amount of radionuclides, including radiocesium, was released and spread over a wide area of eastern Japan. Although three years have passed since the accident, residents around the FNPP are anxious about internal radiation exposure due to radiocesium. In this study, we screened internal radiation exposure doses in Iwaki city of Fukushima prefecture, using a whole-body counter. The first screening was conducted from October 2012 to February 2013, and the second screening was conducted from May to November 2013. Study participants were employees of ALPINE and their families who underwent examination. A total of 2,839 participants (1,366 men and 1,473 women, 1-86 years old) underwent the first screening, and 2,092 (1,022 men and 1,070 women, 1-86 years old) underwent the second screening. The results showed that 99% of subjects registered below 300 Bq per body in the first screening, and all subjects registered below 300 Bq per body in the second screening. The committed effective dose ranged from 0.01-0.06 mSv in the first screening and 0.01-0.02 mSv in the second screening. Long-term follow-up studies are needed to avoid unnecessary chronic internal exposure and to reduce anxiety among the residents by communicating radiation health risks.Entities:
Mesh:
Year: 2014 PMID: 25478794 PMCID: PMC4257669 DOI: 10.1371/journal.pone.0114407
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Location of Iwaki city in Fukushima Prefecture.
Figure 2A vehicle-mounted type of WBC introduced in ALPINE, Iwaki city, Fukushima Prefecture.
a) The large-size car mounted type of WBC. b) The chair equipped with a NaI (T1) scintillation detector.
Number of the study participants.
| First screening (2012) | Second screening (2013) | |||
| Age | Total | Sex (men/women) | Total | Sex (men/women) |
| 0–9 | 181 | 92/89 | 122 | 66/56 |
| 10–19 | 203 | 93/110 | 125 | 53/72 |
| 20–29 | 341 | 144/197 | 248 | 117/131 |
| 30–39 | 666 | 340/326 | 499 | 268/231 |
| 40–49 | 852 | 399/453 | 611 | 282/329 |
| 50–59 | 435 | 218/217 | 365 | 182/183 |
| 60–69 | 109 | 55/54 | 81 | 36/45 |
| 70– | 52 | 25/27 | 41 | 18/23 |
| Total | 2839 | 1366/1473 | 2092 | 1022/1070 |
Detection rate and internal radioactivity.
| Number of participants with detected radioactivity (Detection rate, %) | Internal radioactivity (Bq/Body) Median (minimum–maximum) | ||||
| Screening | n | 134Cs | 137Cs | 134Cs | 137Cs |
| First | 2839 | 12 (0.42%) | 37 (1.30%) | 222 (200–495) | 258 (221–565) |
| Second | 2092 | 0 (0%) | 12 (0.57%) | <200 | 246 (225–289) |
*: <200 as below detection limit, no range can be given.
Figure 3Participants detected with radiocesium in the first screening (a) and the second screening (b).
Figure 4Detection rate of radiocesium by age group.
Number of participants with committed effective doses (mSv).
| Screening | n | <0.01 | 0.01 - | 0.02 - | 0.03 - | 0.04 - | 0.05 - | 0.06 - | 0.07< |
| First | 44 | - | 31 (70.5%) | 7 (15.9%) | 1 (2.3%) | 3 (6.8%) | 1 (2.3%) | 1 (2.3%) | 0(0%) |
| Second | 12 | - | 2 (16.7%) | 10 (83.3%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) |